SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Gaillard Pieter)
 

Search: WFRF:(Gaillard Pieter) > Enhanced Brain Deli...

Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes : A Microdialysis Study

Lindqvist, Annika (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Translational PKPD
Rip, Jaap (author)
Gaillard, Pieter J (author)
show more...
Björkman, Sven (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Translational PKPD
Hammarlund-Udenaes, Margareta (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Translational PKPD
show less...
 (creator_code:org_t)
2012-09-14
2013
English.
In: Molecular Pharmaceutics. - : American Chemical Society (ACS). - 1543-8384 .- 1543-8392. ; 10:5, s. 1533-1541
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Glutathione PEGylated (GSH-PEG) liposomes were evaluated for their ability to enhance and prolong blood-to-brain drug delivery of the opioid peptide DAMGO (H-Tyr-d-Ala-Gly-MePhe-Gly-ol). An intravenous loading dose of DAMGO followed by a 2 h constant rate infusion was administered to rats, and after a washout period of 1 h, GSH-PEG liposomal DAMGO was administered using a similar dosing regimen. DAMGO and GSH-PEG liposomal DAMGO were also administered as a 10 min infusion to compare the disposition of the two formulations. Microdialysis made it possible to determine free DAMGO in brain and plasma, while the GSH-PEG liposomal encapsulated DAMGO was measured with regular plasma sampling. The antinociceptive effect of DAMGO was determined with the tail-flick method. All samples were analyzed using liquid chromatography–tandem mass spectrometry. The short infusion of DAMGO resulted in a fast decline of the peptide concentration in plasma with a half-life of 9.2 ± 2.1 min. Encapsulation in GSH-PEG liposomes prolonged the half-life to 6.9 ± 2.3 h. Free DAMGO entered the brain to a limited extent with a steady state ratio between unbound drug concentrations in brain interstitial fluid and in blood (Kp,uu) of 0.09 ± 0.04. GSH-PEG liposomes significantly increased the brain exposure of DAMGO to a Kp,uu of 0.21 ± 0.17 (p < 0.05). By monitoring the released, active substance in both blood and brain interstitial fluid over time, we were able to demonstrate that GSH-PEG liposomes offer a promising platform for enhancing and prolonging the delivery of drugs to the brain.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

drug delivery
nanocarrier
liposomes
blood-brain barrier
microdialysis
pharmacokinetics
antinociception
opioid peptide
Farmakokinetik och läkemedelsterapi
Pharmacokinetics and Drug Therapy

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Lindqvist, Annik ...
Rip, Jaap
Gaillard, Pieter ...
Björkman, Sven
Hammarlund-Udena ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmaceutical S ...
Articles in the publication
Molecular Pharma ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view